10591710

Source:http://linkedlifedata.com/resource/pubmed/id/10591710

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0032659, umls-concept:C0220812, umls-concept:C0244713, umls-concept:C0751965, umls-concept:C1527178, umls-concept:C1705938, umls-concept:C2603343
pubmed:issue	7224
pubmed:dateCreated	2000-1-21
pubmed:abstractText	To evaluate the cost utility of interferon beta-1b in secondary progressive multiple sclerosis.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/10591710-10109801, http://linkedlifedata.com/resource/pubmed/commentcorrection/10591710-10165310, http://linkedlifedata.com/resource/pubmed/commentcorrection/10591710-10355377, http://linkedlifedata.com/resource/pubmed/commentcorrection/10591710-10877569, http://linkedlifedata.com/resource/pubmed/commentcorrection/10591710-10877570, http://linkedlifedata.com/resource/pubmed/commentcorrection/10591710-10877571, http://linkedlifedata.com/resource/pubmed/commentcorrection/10591710-1306034, http://linkedlifedata.com/resource/pubmed/commentcorrection/10591710-14941968, http://linkedlifedata.com/resource/pubmed/commentcorrection/10591710-2597989, http://linkedlifedata.com/resource/pubmed/commentcorrection/10591710-6847134, http://linkedlifedata.com/resource/pubmed/commentcorrection/10591710-7613530, http://linkedlifedata.com/resource/pubmed/commentcorrection/10591710-8269048, http://linkedlifedata.com/resource/pubmed/commentcorrection/10591710-8469318, http://linkedlifedata.com/resource/pubmed/commentcorrection/10591710-8602746, http://linkedlifedata.com/resource/pubmed/commentcorrection/10591710-8780061, http://linkedlifedata.com/resource/pubmed/commentcorrection/10591710-8916730, http://linkedlifedata.com/resource/pubmed/commentcorrection/10591710-9055730, http://linkedlifedata.com/resource/pubmed/commentcorrection/10591710-9167322, http://linkedlifedata.com/resource/pubmed/commentcorrection/10591710-9354817, http://linkedlifedata.com/resource/pubmed/commentcorrection/10591710-9527179, http://linkedlifedata.com/resource/pubmed/commentcorrection/10591710-9532277, http://linkedlifedata.com/resource/pubmed/commentcorrection/10591710-9576533, http://linkedlifedata.com/resource/pubmed/commentcorrection/10591710-9633699, http://linkedlifedata.com/resource/pubmed/commentcorrection/10591710-9728950, http://linkedlifedata.com/resource/pubmed/commentcorrection/10591710-9804726, http://linkedlifedata.com/resource/pubmed/commentcorrection/10591710-9820292, http://linkedlifedata.com/resource/pubmed/commentcorrection/10591710-9820296, http://linkedlifedata.com/resource/pubmed/commentcorrection/10591710-9820297
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8900488
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Adjuvants, Immunologic, http://linkedlifedata.com/resource/pubmed/chemical/Interferon-beta, http://linkedlifedata.com/resource/pubmed/chemical/interferon beta 1a, http://linkedlifedata.com/resource/pubmed/chemical/interferon beta-1b
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	0959-8138
pubmed:author	pubmed-author:ForbesR BRB, pubmed-author:LeesAA, pubmed-author:SwinglerR JRJ, pubmed-author:WaughNN
pubmed:issnType	Print
pubmed:day	11
pubmed:volume	319
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1529-33
pubmed:dateRevised	2009-11-18
pubmed:meshHeading	pubmed-meshheading:10591710-Activities of Daily Living, pubmed-meshheading:10591710-Adjuvants, Immunologic, pubmed-meshheading:10591710-Cohort Studies, pubmed-meshheading:10591710-Cost-Benefit Analysis, pubmed-meshheading:10591710-Drug Costs, pubmed-meshheading:10591710-Humans, pubmed-meshheading:10591710-Interferon-beta, pubmed-meshheading:10591710-Multiple Sclerosis, pubmed-meshheading:10591710-Quality-Adjusted Life Years, pubmed-meshheading:10591710-Recurrence, pubmed-meshheading:10591710-Scotland, pubmed-meshheading:10591710-Sensitivity and Specificity, pubmed-meshheading:10591710-Wheelchairs
pubmed:year	1999
pubmed:articleTitle	Population based cost utility study of interferon beta-1b in secondary progressive multiple sclerosis.
pubmed:affiliation	Department of Neurology, Ninewells Hospital and Medical School, Dundee DD1 9SY. raeburn.forbes@royalhospitals.n-i.nhs.uk
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't